In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is presenting Spring 2020 events through online platforms and some of our previously scheduled events are being postponed to a later date. Please check our events listing for the latest information and contact our Customer Service team with any additional questions. For Academy programs and resources about COVID-19, click here.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.


Neuroprotective Agents (1)

Edited by Edited by Russell J. Andrews (NASA Ames Research Center, Moffett Field, California), William Slikker, Jr. (National Center for Toxicological Research/FDA, Jefferson, Arkansas), Bruce Trembly (Veterans Affairs Medical Center, Togus, Maine), and Tucker A. Patterson (National Center for Toxicological Research/FDA, Jefferson, Arkansas)
Neuroprotective Agents (1)

Published: June 2010

Volume 1199

Learn More

The ninth in this series of Annals volumes brings together clinical and basic science researchers from several disciplines in a common forum to address various approaches to neuroprotection. Topics covered include the following: optical sensing and neuroprotection; mechanisms of CNS disorders; spinal cord injury; neuromodulation; anesthesia and the immature brain; the blood–brain barrier; cerebrospinal fluid; stress in aging and trauma; heat stress; neurotoxicity; neuroprotective agents; and neuroimaging and neuromonitoring.